FDA product code NTR: Immunohistochemical Reagent, Antibody (Monoclonal Or Polyclonal) To P63 Protein In Nucleus Of Prostatic Basal Cells

NTR is the FDA product code for immunohistochemical reagent, antibody (monoclonal or polyclonal) to p63 protein in nucleus of prostatic basal cells. It is a Class I device, regulated under 21 CFR 864.1860 and reviewed by the Pathology panel. FDA has cleared 1 510(k) submission under NTR. The average 510(k) review took 29 days (median 29). FDA has posted 1 recall for NTR devices.

Definition

MONOCLONAL OR POLYCLONAL ANTIBODY THAT RECOGNIZES THE HUMAN P63 PROTEIN IN THE NUCLEUS OF PROSTATIC BASAL CELLS USING ROUTINE IMMUNOHISTOCHEMICAL TECHNIQUES, INCLUDING HEAT-INDUCED ANTIGEN EPITOPE RETRIEVAL. THIS TEST IS INTENDED FOR LABORATORY USE TO QUALITATIVELY IDENTIFY THE P63 ANTIGEN IN HISTOLOGICAL SECTIONS FROM FORMALIN-FIXED PARAFFIN-EMBEDDED SAMPLES OF NORMAL AND/OR PATHOLOGICAL PROSTATE TISSUE OBTAINED BY NEEDLE BIOPSY OR SURGICAL PROCEDURES. THE PRESENCE OR ABSENCE OF P63 STAINING AIDS THE PATHOLOGIST IN THE DIFFERENTIAL DIAGNOSIS OF PROSTATE CANCER IN CONJUNCTION WITH MORPHOLOGICAL FINDINGS SEEN WITH HEMATOXYLIN AND EOSIN STAINING COMPLEMENTED BY PROPER CONTROLS.

Classification

FieldValue
Device nameImmunohistochemical Reagent, Antibody (Monoclonal Or Polyclonal) To P63 Protein In Nucleus Of Prostatic Basal Cells
Device classClass I
Regulation21 CFR 864.1860
Review panelPA — Pathology
Medical specialtyHematology
Premarket route510(k) exempt

Compare with all 510(k) review times · Search every NTR clearance

Top NTR applicants

ApplicantClearancesLatest
Asymmetrx12005-02-09

Most recent NTR clearances

510(k)ApplicantDeviceDecision dateReview days
K050063AsymmetrxPROSTATE-63 CANCER DIAGNOSTIC TEST2005-02-0929

Recalls for NTR devices

1 product recalls in 1 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2015-10-27.

Frequently asked questions

What is FDA product code NTR?

NTR is the FDA product code for immunohistochemical reagent, antibody (monoclonal or polyclonal) to p63 protein in nucleus of prostatic basal cells. It is a Class I device, regulated under 21 CFR 864.1860 and reviewed by the Pathology panel.

What device class is NTR?

Class I, regulation 21 CFR 864.1860. Typical premarket route: 510(k) exempt.

How long does a 510(k) take for product code NTR?

Across 1 cleared submissions the average was 29 days from receipt to decision (median 29).

Which companies have the most NTR clearances?

Asymmetrx (1).

Have NTR devices been recalled?

Yes: 1 product recalls across 1 recall events; the most recent began 2015-10-27.

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Pathology product codes · FDA product code lookup · 510(k) database search · 510(k) review times